PBM

The Trump administration has decided not to pursue a policy that would have put an end to rebates paid to pharmacy benefit managers, which could put the focus again on how drug companies set their prices. The proposal would have barred drug companies from paying rebates to PBMs that participate in Medicare and other government […]